Development and validation of hierarchical signature for precision individualized therapy based on the landscape associated with necroptosis in clear cell renal cell carcinoma
The necroptosis-related signature we constructed can accurately predict the prognosis of ccRCC patients and further provide clues for targeted, individualized therapy.
Authors
- Liangmin Fu (ORCID: https://orcid.org/0000-0001-8038-4742)
- Lei Dai (ORCID: https://orcid.org/0000-0001-5742-1963)
- Junshang Dai (ORCID: https://orcid.org/0000-0002-5619-7768)
- Juan Lin (ORCID: https://orcid.org/0009-0005-1321-5793)
- Zhiping Tan (ORCID: https://orcid.org/0000-0002-5331-0980)
- Junhang Luo (ORCID: https://orcid.org/0000-0002-9170-9757)
- Jinhuan Wei (ORCID: https://orcid.org/0000-0003-0179-6250)
- Wei Chen (ORCID: https://orcid.org/0000-0002-2139-1368)
- G YAO
Institutions
- Central South University (CN)
- Sun Yat-sen University (CN)
- Chinese University of Hong Kong (HK)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-04
- DOI
- https://doi.org/10.3389/fphar.2025.1470145
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00